-
1دورية أكاديمية
المساهمون: Yong Hoon Kim, Ae-Young Her, Myung Ho Jeong, Byeong-Keuk Kim, Sung-Jin Hong, Seunghwan Kim, Chul-Min Ahn, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang, Ko, Young Guk
مصطلحات موضوعية: Aged, Angiotensin II Type 1 Receptor Blockers / therapeutic use, Angiotensin-Converting Enzyme Inhibitors / therapeutic use, Dyslipidemias / complications, Dyslipidemias / drug therapy, Female, Humans, Male, Middle Aged, Myocardial Infarction / complications, Myocardial Infarction / drug therapy, Myocardial Infarction / mortality, Myocardial Infarction / surgery, Registries, Republic of Korea, Stents, Treatment Outcome, dyslipidemia, myocardial infarction, renin-angiotensin system
العلاقة: ANATOLIAN JOURNAL OF CARDIOLOGY; J00137; OAK-2022-03896; OAK-2022-03897; OAK-2022-03898; OAK-2022-03899; OAK-2022-03900; OAK-2022-03901; OAK-2022-03902; OAK-2022-03903; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190227Test; T9992020452; ANATOLIAN JOURNAL OF CARDIOLOGY, Vol.23(2) : 86-98, 2020-02
الإتاحة: https://doi.org/10.14744/AnatolJCardiol.2019.60374Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190227Test -
2
-
3دورية أكاديمية
المساهمون: Jong Chan Youn, Sang Hyun Ihm, Jang Ho Bae, Seong Mi Park, Dong Woon Jeon, Byung Chun Jung, Tae Ho Park, Nae Hee Lee, Jong Min Song, Young Won Yoon, Eun Seok Shin, Ki Chul Sung, In Hyun Jung, Wook Bum Pyun, Seung Jae Joo, Woo Jung Park, Jin Ho Shin, Seok Min Kang, Kang, Seok Min, Yoon, Young Won, Youn, Jong Chan
مصطلحات موضوعية: Adult, Angiotensin II Type 1 Receptor Blockers/adverse effects, Angiotensin II Type 1 Receptor Blockers/therapeutic use, Antihypertensive Agents/adverse effects, Antihypertensive Agents/therapeutic use, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use, Blood Pressure/drug effects, Double-Blind Method, Female, Humans, Hypertension/drug therapy, Hypertension/physiopathology, Male, Middle Aged, Pyrimidines/adverse effects, Pyrimidines/therapeutic use, Tetrazoles/adverse effects, Tetrazoles/therapeutic use, Treatment Outcome, Valsartan/adverse effects, Valsartan/therapeutic use, fimasartan, hypertension, placebo, valsartan
وصف الملف: 1412~1421
العلاقة: CLINICAL THERAPEUTICS; J00614; OAK-2014-03010; https://ir.ymlib.yonsei.ac.kr/handle/22282913/138743Test; http://www.sciencedirect.com/science/article/pii/S0149291814004391Test; T201405549; CLINICAL THERAPEUTICS, Vol.36(10) : 1412-1421, 2014
الإتاحة: https://doi.org/10.1016/j.clinthera.2014.07.004Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/138743Test
http://www.sciencedirect.com/science/article/pii/S0149291814004391Test -
4دورية أكاديمية
المساهمون: Sung Kyu Ha, Ha, Sung Kyu
المصدر: T201404602.pdf
مصطلحات موضوعية: Angiotensin II Type 1 Receptor Blockers/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Animals, Diabetic Nephropathies/drug therapy, Diabetic Nephropathies/enzymology, Diabetic Nephropathies/genetics, Disease Progression, Genetic Predisposition to Disease, Humans, Kidney Failure, Chronic/drug therapy, Chronic/enzymology, Chronic/genetics, Peptidyl-Dipeptidase A/genetics, Phenotype, Polymorphism, Genetic, Proteinuria/drug therapy, Proteinuria/enzymology, Proteinuria/genetics, Renin-Angiotensin System/drug effects, Renin-Angiotensin System/genetics, Risk Factors, Treatment Outcome
وصف الملف: application/pdf
العلاقة: JOURNAL OF DIABETES RESEARCH; J01378; OAK-2014-02707; https://ir.ymlib.yonsei.ac.kr/handle/22282913/138440Test; T201404602; JOURNAL OF DIABETES RESEARCH, Vol.2014 : 846068, 2014
الإتاحة: https://doi.org/10.1155/2014/846068Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/138440Test -
5دورية أكاديمية
المؤلفون: Lögstrup Poulsen, P, Wurgler Hansen, K, Gaede, P H, Rossing, P
المصدر: Ugeskrift for Laeger. 171(24):2031
-
6دورية أكاديمية
المساهمون: Bum-Kee Hong, Chang Gyu Park, Ki Sik Kim, Myeong Ho Yoon, Ho Joong Yoon, Jeong Han Yoon, Joo Young Yang, Young Jin Choi, Prof. Seung Yun Cho, Cho, Seung Yun, Hong, Bum Kee
مصطلحات موضوعية: Adult, Amlodipine/administration & dosage, Amlodipine/adverse effects, Amlodipine/therapeutic use, Angiotensin II Type 1 Receptor Blockers/administration & dosage, Angiotensin II Type 1 Receptor Blockers/adverse effects, Angiotensin II Type 1 Receptor Blockers/therapeutic use, Antihypertensive Agents/administration & dosage, Antihypertensive Agents/adverse effects, Antihypertensive Agents/therapeutic use, Blood Pressure/drug effects, Calcium Channel Blockers/administration & dosage, Calcium Channel Blockers/adverse effects, Calcium Channel Blockers/therapeutic use, Double-Blind Method, Drug Combinations, Female, Humans, Hypertension/drug therapy, Hypertension/physiopathology, Losartan/administration & dosage, Losartan/adverse effects, Losartan/therapeutic use, Male, Middle Aged, Republic of Korea, Time Factors, Treatment Outcome, Diastolic Blood Pressure, Losartan
العلاقة: AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS; J00072; OAK-2012-01470; https://ir.ymlib.yonsei.ac.kr/handle/22282913/89411Test; http://link.springer.com/article/10.2165%2F11597410-000000000-00000Test; T201202935; AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, Vol.12(3) : 189-195, 2012
-
7دورية أكاديمية
المؤلفون: Scheen, André
المصدر: Revue Médicale de Liège, 65 (4), 217-23 (2010)
مصطلحات موضوعية: Angiotensin II Type 1 Receptor Blockers/therapeutic use, Belgium, Cardiovascular Diseases/etiology/prevention & control, Cyclohexanes/therapeutic use, Diabetes Mellitus, Type 2/complications/drug therapy/prevention & control, Double-Blind Method, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Hypoglycemic Agents/therapeutic use, Male, Middle Aged, Phenylalanine/analogs & derivatives/therapeutic use, Renin-Angiotensin System/drug effects, Tetrazoles/therapeutic use, Treatment Outcome, Valine/analogs & derivatives/therapeutic use, Human health sciences, Endocrinology, metabolism & nutrition, Cardiovascular & respiratory systems, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Systèmes cardiovasculaire & respiratoire
العلاقة: http://www.rmlg.ulg.ac.beTest; urn:issn:0370-629X; urn:issn:2566-1566
الوصول الحر: https://orbi.uliege.be/handle/2268/66439Test
-
8دورية أكاديمية
المؤلفون: Nakano, Anne, Vinter, Nicklas, Egstrup, Kenneth, Svendsen, Marie Louise, Schjødt, Inge, Johnsen, Søren Paaske
المصدر: Nakano , A , Vinter , N , Egstrup , K , Svendsen , M L , Schjødt , I & Johnsen , S P 2019 , ' Association between process performance measures and 1-year mortality among patients with incident heart failure : a Danish nationwide study ' , European heart journal. Quality of care & clinical outcomes , vol. 5 , no. 1 , pp. 28-34 . https://doi.org/10.1093/ehjqcco/qcy041Test
مصطلحات موضوعية: Clinical registries, Heart failure, Mortality, Performance measures, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure/diagnostic imaging, Echocardiography, Follow-Up Studies, Humans, Middle Aged, Angiotensin II Type 1 Receptor Blockers/therapeutic use, Male, Treatment Outcome, Adrenergic beta-Antagonists/therapeutic use, Exercise Therapy, Process Assessment (Health Care), Denmark/epidemiology, Guideline Adherence, Aged, 80 and over, Female, Registries, Patient Education as Topic, Practice Guidelines as Topic
الإتاحة: https://doi.org/10.1093/ehjqcco/qcy041Test
https://vbn.aau.dk/da/publications/2a4eb5e4-9261-46df-adc3-588035c2d259Test
http://www.scopus.com/inward/record.url?scp=85059243975&partnerID=8YFLogxKTest -
9
المؤلفون: Anne Nakano, Inge Schjødt, Nicklas Vinter, Marie Louise Svendsen, Søren Paaske Johnsen, Kenneth Egstrup
المصدر: Nakano, A, Vinter, N, Egstrup, K, Svendsen, M L, Schjødt, I & Johnsen, S P 2019, ' Association between process performance measures and 1-year mortality among patients with incident heart failure : a Danish nationwide study ', European heart journal. Quality of care & clinical outcomes, vol. 5, no. 1, pp. 28-34 . https://doi.org/10.1093/ehjqcco/qcy041Test
Nakano, A, Vinter, N, Egstrup, K, Svendsen, M L, Schjødt, I & Johnsen, S P 2019, ' Association between process performance measures and 1-year mortality among patients with incident heart failure : a Danish nationwide study ', European Heart Journal-Quality of Care and Clinical Outcomes, vol. 5, no. 1, pp. 28-34 . https://doi.org/10.1093/ehjqcco/qcy041Testمصطلحات موضوعية: Male, Denmark, Angiotensin-Converting Enzyme Inhibitors, 030204 cardiovascular system & hematology, 0302 clinical medicine, 030212 general & internal medicine, Registries, Aged, 80 and over, education.field_of_study, Process Assessment (Health Care), Health Policy, Hazard ratio, Confounding, Process Assessment, Health Care, Middle Aged, Adrenergic beta-Antagonists/therapeutic use, Exercise Therapy, Heart Failure/diagnostic imaging, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Treatment Outcome, Echocardiography, Practice Guidelines as Topic, Female, Guideline Adherence, Cardiology and Cardiovascular Medicine, medicine.medical_specialty, Angiotensin II Type 1 Receptor Blockers/therapeutic use, Performance measures, Concordance, Population, Adrenergic beta-Antagonists, Heart failure, 03 medical and health sciences, Patient Education as Topic, Internal medicine, medicine, Humans, Mortality, education, Aged, Heart Failure, Clinical registries, business.industry, Guideline, medicine.disease, Confidence interval, Denmark/epidemiology, business, Angiotensin II Type 1 Receptor Blockers, Patient education, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84098a662db9e0663424e1e0ff5482f9Test
https://vbn.aau.dk/da/publications/2a4eb5e4-9261-46df-adc3-588035c2d259Test -
10دورية أكاديمية
المؤلفون: Redon, J., Pichler, G.
المساهمون: Missed Dose Study Group, Redon, J., Pascual, J.M., Olivan-Martinez, J., Martell, N., Calvo-Gomez, C., Lembo, G., Benedetto, F.A., De Curtis, G., Desideri, G., Dognini, G.P., Ferri, C., Fogari, R., Ganau, A., Gargiulo, A., Gaudio, G., Germanò, G., Malatino, L., Bucci, M., Mos, L., Novo, S., Pedrinelli, R., Perticone, F., Portaluppi, F., Mulé, G., Sarzani, R., Schillaci, G., Spagnuolo, V., Strazzullo, P., Taddei, S., Trimarco, B., Veglio, F., Verdecchia, P., Volpe, M., Tsioufis, C., Zakopoulos, N., Zamboulis, C., Schmieder, R.E., Bönner, G., Sehnert, W., Haller, H., Scholze, J., Burnier, M., Hayoz, D., Asmar, R., Blacher, J., Benetos, A., Gosse, P., Mounier-Vehier, C., Thuillez, C.
المصدر: Journal of hypertension, vol. 34, no. 2, pp. 359-367
مصطلحات موضوعية: Adult, Aged, Amlodipine/adverse effects, Amlodipine/therapeutic use, Angiotensin II Type 1 Receptor Blockers/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Antihypertensive Agents/adverse effects, Antihypertensive Agents/therapeutic use, Blood Pressure/drug effects, Calcium Channel Blockers/therapeutic use, Diabetes Mellitus, Type 2/complications, Double-Blind Method, Drug Combinations, Female, Humans, Hypertension/complications, Hypertension/drug therapy, Imidazoles/adverse effects, Imidazoles/therapeutic use, Male, Medication Adherence, Middle Aged, Perindopril/adverse effects, Perindopril/therapeutic use, Tetrazoles/adverse effects, Tetrazoles/therapeutic use, Treatment Outcome
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26867060; info:eu-repo/semantics/altIdentifier/eissn/1473-5598; https://serval.unil.ch/notice/serval:BIB_C026E9F13CC7Test; urn:issn:0263-6352
الإتاحة: https://doi.org/10.1097/HJH.0000000000000793Test
https://serval.unil.ch/notice/serval:BIB_C026E9F13CC7Test